The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation
Abstract
BACKGROUND: Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge repair of severe mitral regurgitation, as compared with outcomes after maximal doses of guideline-directed medical therapy alone, in patients with heart failure are now available. METHODS: We randomly assigned patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy to undergo transcatheter edge-to-edge repair plus receive medical therapy (device group) or to receive medical therapy alone (control group) at 78 sites in the United States and Canada. The primary effectiveness end point was all hospitalizations for heart failure through 2 years of follow-up. The annualized rate of all hospitalizations for heart failure, all-cause mortality, the risk of death or hospitalization for heart failure, and safety, among other outcomes, were assessed through 5 years. RESULTS: Of the 614 patients enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of hospitalization for heart failure through 5 years was 33.1% per year in the device group and 57.2% per year in the control group (hazard ratio, 0.53; 95% confidence interval [CI], 0.41 to 0.68). All-cause mortality through 5 years was 57.3% in the device group and 67.2% in the control group (hazard ratio, 0.72; 95% CI, 0.58 to 0.89). Death or hospitalization for heart failure within 5 years occurred in 73.6% of the patients in the device group and in 91.5% of those in the control group (hazard ratio, 0.53; 95% CI, 0.44 to 0.64). Device-specific safety events within 5 years occurred in 4 of 293 treated patients (1.4%), with all the events occurring within 30 days after the procedure. CONCLUSIONS: Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite guideline-directed medical therapy, transcatheter edge-to-edge repair of the mitral valve was safe and led to a lower rate of hospitalization for heart failure and lower all-cause mortality through 5 years of follow-up than medical therapy alone. (Funded by Abbott; COAPT ClinicalTrials.gov number, NCT01626079.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationTranscatheter Mitral-Valve Repair in Patients with Heart Failure
Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
Self-citationMitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation
Acker, M. A., Parides, M. K., Perrault, L. P., Moskowitz, A. J., Gelijns, A. C., Voisine, P., Smith, P. K., Hung, J. W., Blackstone, E. H., Puskas, J. D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312808 · Cited by 947
Self-citationPercutaneous Mitral Repair With the MitraClip System
Feldman, T., Kar, S., Rinaldi, M., Fail, P., Hermiller, J., Smalling, R., Whitlow, P. L., Gray, W., Low, R., Herrmann, H. C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.077 · Cited by 932
Self-citationStone, G. W., Adams, D. H., Abraham, W. T., Kappetein, A. P., Généreux, P., Vranckx, P., Mehran, R., Kuck, K.-H., Leon, M. B., Piazza, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.049 · Cited by 594
Self-citationSecondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Self-citationRefining the prognostic impact of functional mitral regurgitation in chronic heart failure
Goliasch, G., Bartko, P. E., Pavo, N., Neuhold, S., Wurm, R., Mascherbauer, J., Lang, I. M., Strunk, G., & Hülsmann, M. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx402 · Cited by 361
Stone, G. W., Vahanian, A. S., Adams, D. H., Abraham, W. T., Borer, J. S., Bax, J. J., Schofer, J., Cutlip, D. E., Krucoff, M. W., Blackstone, E. H., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.046 · Cited by 239
Self-citationSannino, A., Smith, R. L., Schiattarella, G. G., Trimarco, B., Esposito, G., & Grayburn, P. A. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2976 · Cited by 235
Self-citationRondeau, V., Mathoulin-Pelissier, S., Jacqmin-Gadda, H., Brouste, V., & Soubeyran, P. (2006) · Biostatistics · doi:10.1093/biostatistics/kxl043 · Cited by 211
Asch, F. M., Grayburn, P. A., Siegel, R. J., Kar, S., Lim, D. S., Zaroff, J. G., Mishell, J. M., Whisenant, B., Mack, M. J., Lindenfeld, J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.017 · Cited by 206
Self-citationLim, D. S., Smith, R. L., Gillam, L. D., Zahr, F. E., Chadderdon, S. M., Makkar, R., von Bardeleben, R. S., Kipperman, R., Rassi, A. N., Szerlip, M., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.09.005 · Cited by 166
Self-citationMack, M. J., Abraham, W. T., Lindenfeld, J., Bolling, S. F., Feldman, T. E., Grayburn, P. A., Kapadia, S. R., McCarthy, P. M., Lim, D. S., Udelson, J. E., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.07.021 · Cited by 115
Self-citationBaron, S. J., Wang, K., Arnold, S. V., Magnuson, E. A., Whisenant, B. K., Brieke, A., Rinaldi, M., Asgar, A., Lindenfeld, J. M., Abraham, W. T., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.043275 · Cited by 79
Self-citationMitral Valve Surgery After Transcatheter Edge-to-Edge Repair
Kaneko, T., Hirji, S. A., Zaid, S., Lange, R., Kempfert, J., Conradi, L., Hagl, C. M., Borger, M. A., Taramasso, M., Nguyen, T. C., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.07.029 · Cited by 58
Self-citationAhmad, Y., Madhavan, M. V., Stone, G. W., Francis, D. P., Makkar, R., Bhatt, D. L., & Howard, J. P. (2021) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcab072 · Cited by 24
Self-citationArnold, S. V., Stone, G. W., Jain, S. S., Mack, M. J., Saxon, J. T., Zhang, Z., Lindenfeld, J. M., Abraham, W. T., & Cohen, D. J. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.04.012 · Cited by 18
Self-citation
Cited by
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics
Timmis, A., Aboyans, V., Vardas, P., Townsend, N., Torbica, A., Kavousi, M., Boriani, G., Huculeci, R., Kazakiewicz, D., Scherr, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae466 · Cited by 314
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation
Anker, S. D., Friede, T., von Bardeleben, R.-S., Butler, J., Khan, M.-S., Diek, M., Heinrich, J., Geyer, M., Placzek, M., Ferrari, R., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2314328 · Cited by 275
Self-citation
Metadata
- Authors
- Stone, G. W., Abraham, W. T., Lindenfeld, J., Kar, S., Grayburn, P. A., Lim, D. S., Mishell, J. M., Whisenant, B., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Marx, S. O., Cohen, D. J., Asch, F. M., & Mack, M. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-06
- Volume
- 388
- Issue
- 22
- Pages
- 2037-2048
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4323262080
- Cited by
- 369
- References
- 22
- FWCI
- 64.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.